Prognostic implications of epigenetic silencing of p15INK4B in acute promyelocytic leukemia.
Department of Leukemia, University of Texas MD Anderson Cancer Center Houston, TX 77030, USA.
Guillermo
G
Garcia-Manero
D018797:Cell Cycle Proteins / Q000235:genetics* / Q000378:metabolism; D050762:Cyclin-Dependent Kinase Inhibitor p15; D019941:Cyclin-Dependent Kinase Inhibitor p16 / Q000235:genetics* / Q000378:metabolism; D019175:DNA Methylation; D015226:Dinucleoside Phosphates / Q000235:genetics; D020868:Gene Silencing; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000235:genetics* / Q000473:pathology; D011379:Prognosis; D011401:Promoter Regions, Genetic / Q000235:genetics; D025521:Tumor Suppressor Proteins
C493966:CDKN2B protein, human; D018797:Cell Cycle Proteins; D050762:Cyclin-Dependent Kinase Inhibitor p15; D019941:Cyclin-Dependent Kinase Inhibitor p16; D015226:Dinucleoside Phosphates; D025521:Tumor Suppressor Proteins; C018309:guanylyl-(3'-5')-guanosine